GO:0001732 formation of cytoplasmic translation initiation complex: Protein Synthesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001732 describes the joining of the large ribosomal subunit with the translation preinitiation complex, releasing IF2/eIF2 and IF3/eIF3 or IF5B/eIF5B, leaving the functional ribosome at the AUG with the methionyl/formyl-methionyl-tRNA at the P site.
• This step is the final commitment step of translation initiation and is conserved from bacteria to eukaryotes, with eIF5B (IF2 homolog) catalyzing subunit joining in eukaryotes.
• The process is tightly regulated by mTORC1 signaling, which controls the availability of initiation factors and the efficiency of translation initiation.
• Dysregulation of translation initiation complex formation contributes to cancer, neurodegeneration, and ribosomopathies, making it a therapeutic target.
• Key experimental approaches include ribosome profiling, structural biology (cryo-EM), and CRISPR-based genetic screens to dissect factor requirements.
• EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression cell models and library screening to study genes involved in this process.
Description
The formation of the cytoplasmic translation initiation complex (GO:0001732) is a pivotal step in protein synthesis, where the large ribosomal subunit joins the preinitiation complex to form an elongation-competent 80S ribosome. This process ensures that the start codon is correctly positioned in the ribosomal P site, with the initiator methionyl-tRNA base-paired to AUG. In eukaryotes, this step is catalyzed by the GTPase eIF5B (a homolog of bacterial IF2), which facilitates subunit joining and is released upon GTP hydrolysis. The reaction also involves the release of eIF2 and eIF3, which had been part of the preinitiation complex. This step is a major regulatory node for gene expression and is targeted by signaling pathways such as mTORC1. Researchers study GO:0001732 to understand how cells control protein synthesis under normal and pathological conditions, and to identify therapeutic targets in diseases like cancer and neurodegeneration.
formation of cytoplasmic translation initiation complex At A Glance
| GO ID | GO:0001732 |
|---|---|
| GO term | formation of cytoplasmic translation initiation complex |
| Ontology | biological_process |
| Synonym | cytoplasmic translation initiation complex assembly; formation of translation initiation complex; translation initiation complex assembly |
| Major function | Joining of the large ribosomal subunit with the preinitiation complex, release of initiation factors, and positioning of initiator tRNA at the P site |
| Organisms | Eukaryotes (cytoplasmic) and bacteria (functionally conserved) |
| Key factors | eIF5B (eukaryotes), IF2 (bacteria), eIF2, eIF3, large ribosomal subunit |
| Regulation | mTORC1 signaling, phosphorylation of eIF2α, availability of initiation factors |
What Is GO:0001732?
GO:0001732, formation of cytoplasmic translation initiation complex, is defined as the joining of the large ribosomal subunit with the translation preinitiation complex, with release of IF2/eIF2 and IF3/eIF3 or IF5B/eIF5B. This leaves the functional ribosome at the AUG, with the methionyl/formyl-methionyl-tRNA positioned at the P site. It is a biological process that represents the final step of translation initiation, resulting in a competent 80S ribosome ready for elongation.
Why Is formation of cytoplasmic translation initiation complex Important in Cell Biology?
The formation of the cytoplasmic translation initiation complex is a critical control point in gene expression, as it determines the efficiency and fidelity of protein synthesis. Dysregulation of this process is linked to a wide range of human diseases, including cancer, where increased translation initiation supports oncogenic growth, and neurodegeneration, where impaired translation contributes to neuronal death. Moreover, this step is a target for therapeutic intervention, and understanding its molecular details can guide the development of novel drugs.
• Controls the final step of translation initiation, committing the ribosome to protein synthesis.
• Regulated by mTORC1, which integrates nutrient and growth signals to modulate translation.
• Dysregulated in cancer, where oncogenes drive increased translation initiation.
• Implicated in neurodegeneration, as impaired translation initiation leads to neuronal dysfunction.
• Targeted by antibiotics and potential antiviral drugs.
• Essential for viral infection, as many viruses hijack the host translation machinery.
• Plays a role in ribosomopathies, where mutations in ribosomal proteins affect translation.
• Can be studied using ribosome profiling to measure translation efficiency.
• Structural studies reveal conserved mechanisms and species-specific features.
• CRISPR screens can identify genes required for this process.
What Happens During formation of cytoplasmic translation initiation complex?
Recruitment of the large ribosomal subunit
In simple terms: The big part of the ribosome attaches to the small part that is already holding the mRNA and the start tRNA.
In this step, the 60S large ribosomal subunit joins the 48S preinitiation complex, which contains the 40S subunit, mRNA, and initiator methionyl-tRNA. This joining is facilitated by the GTPase eIF5B in eukaryotes (IF2 in bacteria). The interaction between eIF5B and the 60S subunit triggers conformational changes that lead to the formation of the 80S ribosome.
Release of initiation factors
In simple terms: Helper proteins that were needed to start the process are let go.
Upon subunit joining, eIF2 and eIF3 (or IF2 and IF3 in bacteria) are released from the complex. In eukaryotes, eIF5B also dissociates after GTP hydrolysis, leaving the 80S ribosome with the initiator tRNA positioned at the P site. This release is essential for the ribosome to proceed to elongation.
Positioning of the initiator tRNA at the P site
In simple terms: The first tRNA is placed exactly where it needs to be to start making the protein.
The initiator methionyl-tRNA is positioned at the ribosomal P site, base-paired with the AUG start codon on the mRNA. This positioning is crucial for the fidelity of translation initiation and ensures that the correct reading frame is established. Structural studies have revealed the precise interactions that stabilize this state.
GTP hydrolysis and conformational changes
In simple terms: A energy molecule is used to lock the parts together and trigger changes.
eIF5B (or IF2) hydrolyzes GTP to GDP and Pi, which drives conformational changes in the ribosome and leads to the release of the factor. This step is tightly regulated and ensures that only correctly assembled complexes proceed to elongation. The energy from GTP hydrolysis is used to proofread the initiation process.
Quality control and fidelity
In simple terms: The cell checks that everything is correct before starting protein production.
Multiple checkpoints ensure that the initiator tRNA is correctly base-paired with the start codon and that the ribosome is properly assembled. If errors are detected, the complex can be disassembled or the process aborted. This quality control is essential to prevent translation of aberrant proteins.
Key Genes Involved in GO:0001732 formation of cytoplasmic translation initiation complex
The following genes and proteins are key players in the formation of the cytoplasmic translation initiation complex, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EIF5B | GTPase that catalyzes subunit joining and release of eIF2/eIF3 | Central factor; knockout causes severe translation defects |
| EIF2S1 | Alpha subunit of eIF2; delivers initiator tRNA to 40S | Phosphorylation regulates global translation |
| EIF2S2 | Beta subunit of eIF2 | Part of ternary complex; mutations affect translation |
| EIF2S3 | Gamma subunit of eIF2; binds GTP and tRNA | Mutations linked to intellectual disability |
| EIF3A | Core subunit of eIF3; promotes preinitiation complex assembly | Knockdown impairs translation initiation |
| EIF3B | RNA-binding subunit of eIF3 | Required for efficient initiation |
| EIF3C | Core subunit of eIF3 | Involved in scanning and AUG recognition |
| EIF3D | Cap-binding subunit of eIF3 | Plays a role in cap-dependent translation |
| EIF3E | Subunit of eIF3 | Implicated in cancer |
| EIF3F | Subunit of eIF3 | Regulates translation and cell growth |
| EIF3G | RNA-binding subunit of eIF3 | Modulates initiation |
| EIF3H | Subunit of eIF3 | Overexpressed in cancers |
| EIF3I | Subunit of eIF3 | Required for translation |
| EIF3J | Subunit of eIF3 | Involved in subunit joining |
| EIF3K | Subunit of eIF3 | Less characterized |
| EIF3L | Subunit of eIF3 | Part of the eIF3 complex |
| EIF3M | Subunit of eIF3 | Essential for translation |
| RPS6 | Ribosomal protein of 40S subunit | Phosphorylated by S6K; marker of mTORC1 activity |
How Is formation of cytoplasmic translation initiation complex Regulated?
The formation of the cytoplasmic translation initiation complex is regulated by multiple signaling pathways, most notably mTORC1, which promotes translation initiation by phosphorylating downstream effectors such as S6K1 and 4E-BP1. Additionally, phosphorylation of eIF2α by kinases like PERK, PKR, GCN2, and HRI inhibits ternary complex formation and reduces initiation. Other regulatory mechanisms include the availability of initiation factors, post-translational modifications, and the presence of RNA-binding proteins that modulate mRNA translation.
formation of cytoplasmic translation initiation complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EIF5B | Cancer, translation defects | Knockout cell lines, xenograft models |
| EIF2S1 | Neurodegeneration, ISR | Point mutation (S51A) knock-in mice |
| EIF3E | Breast cancer | Overexpression and knockout cell lines |
| EIF3H | Hepatocellular carcinoma | Knockdown and overexpression models |
| RPS6 | mTORC1-related disorders | Phospho-mutant knock-in |
Cancer
Dysregulated translation initiation is a hallmark of cancer. Oncogenes such as MYC and RAS drive increased expression of initiation factors, including eIF4E and eIF3 subunits, promoting tumor growth and survival. Targeting the formation of the translation initiation complex is a promising therapeutic strategy.
Neurodegeneration
Impaired translation initiation contributes to neuronal dysfunction in diseases such as Alzheimer's and Parkinson's. Phosphorylation of eIF2α is a common feature in neurodegeneration, leading to reduced global translation and synaptic failure.
Ribosomopathies
Mutations in ribosomal proteins or initiation factors can cause ribosomopathies like Diamond-Blackfan anemia and Shwachman-Diamond syndrome. These disorders often involve defects in translation initiation complex formation.
Viral infections
Many viruses hijack the host translation machinery to synthesize viral proteins. Some viruses encode their own initiation factors or IRES elements to recruit ribosomes, and understanding these mechanisms can inform antiviral strategies.
From formation of cytoplasmic translation initiation complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of EIF5B knockout on translation? | CRISPR knockout cell lines |
| How does eIF2α phosphorylation affect initiation? | Point mutation (S51A) knock-in |
| Can we tag eIF5B to study its localization? | Tagged knock-in (e.g., GFP) |
| Does overexpression of eIF3E promote transformation? | Overexpression cell lines |
| Which genes are essential for translation initiation? | Genome-wide CRISPR library screening |
| What is the structural basis of subunit joining? | Cryo-EM and biochemical assays |
How to Study the formation of cytoplasmic translation initiation complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribosome profiling | Translation efficiency and ribosome occupancy | Global translation analysis |
| Cryo-EM | 3D structure of macromolecular complexes | Structural basis of initiation |
| In vitro reconstitution | Biochemical activity of initiation factors | Mechanistic studies |
| CRISPR knockout screens | Gene essentiality and fitness | Identify novel factors |
| Polysome profiling | Distribution of mRNAs in polysomes | Translation initiation efficiency |
| Western blot | Protein expression and phosphorylation | Validate signaling changes |
| Immunofluorescence | Localization of initiation factors | Cellular imaging |
Ribosome profiling
Ribosome profiling (Ribo-seq) provides a genome-wide snapshot of translation by sequencing ribosome-protected mRNA fragments. It can measure translation efficiency and identify changes in initiation in response to genetic perturbations.
Structural biology
Cryo-electron microscopy (cryo-EM) and X-ray crystallography have revealed the molecular architecture of the translation initiation complex, including the interactions between eIF5B and the ribosome.
Biochemical assays
In vitro reconstitution assays using purified components can dissect the steps of subunit joining and factor release. GTP hydrolysis assays and fluorescence-based techniques are commonly used.
CRISPR screens
Genome-wide CRISPR knockout screens can identify genes required for translation initiation and cell viability, providing insights into the genetic network.
How CRISPR Can Be Used to Study GO:0001732 formation of cytoplasmic translation initiation complex
Knockout
CRISPR knockout of genes such as EIF5B, EIF2S1, or EIF3 subunits can abolish translation initiation complex formation, leading to cell lethality or severe growth defects. These models are useful to study the essentiality of individual factors.
Point Mutation
Point mutations can be introduced to mimic phosphorylation or inactivate catalytic residues. For example, the S51A mutation in eIF2α prevents phosphorylation and alters translation regulation.
Knock-in
Knock-in of tagged versions of initiation factors (e.g., GFP-eIF5B) allows live-cell imaging and proteomic analysis of complex assembly.
Overexpression
Overexpression of initiation factors like eIF4E or eIF3 subunits can drive oncogenic transformation and is used to model cancer.
How EDITGENE Supports formation of cytoplasmic translation initiation complex Research
Researchers studying formation of cytoplasmic translation initiation complex-related genes often need to determine whether a candidate gene is causally involved in the process, and to dissect its molecular function. EDITGENE provides a comprehensive suite of CRISPR services to enable such studies.
Contact EDITGENE today to design your custom CRISPR model for formation of cytoplasmic translation initiation complex research.
Frequently Asked Questions About formation of cytoplasmic translation initiation complex
What is GO:0001732?
GO:0001732 is the Gene Ontology term for the formation of the cytoplasmic translation initiation complex, the step where the large ribosomal subunit joins the preinitiation complex, releasing initiation factors and positioning the initiator tRNA at the P site.
What genes are involved in formation of cytoplasmic translation initiation complex?
Key genes include EIF5B, EIF2S1, EIF2S2, EIF2S3, and subunits of EIF3, as well as ribosomal proteins.
How is the formation of the translation initiation complex regulated?
It is regulated by mTORC1 signaling, eIF2α phosphorylation, and the availability of initiation factors.
What diseases are associated with defects in translation initiation complex formation?
Cancer, neurodegeneration, ribosomopathies, and viral infections are linked to dysregulation of this process.
What methods are used to study translation initiation complex formation?
Ribosome profiling, cryo-EM, in vitro reconstitution, and CRISPR screens are commonly used.
Can CRISPR be used to study translation initiation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect gene function in translation initiation.
What is the role of eIF5B in translation initiation?
eIF5B is a GTPase that catalyzes the joining of the 60S subunit to the 48S preinitiation complex and is released after GTP hydrolysis.
How does mTORC1 regulate translation initiation?
mTORC1 phosphorylates S6K1 and 4E-BP1, promoting the assembly of the translation initiation complex and enhancing protein synthesis.
What is the difference between prokaryotic and eukaryotic translation initiation complex formation?
While the core process is conserved, eukaryotes use eIF5B and additional factors, whereas bacteria use IF2 and IF3.
What are the consequences of eIF2α phosphorylation?
Phosphorylation of eIF2α inhibits ternary complex formation, reducing global translation initiation and activating the integrated stress response.
Conclusion
The formation of the cytoplasmic translation initiation complex (GO:0001732) is a fundamental biological process that controls protein synthesis and is tightly regulated by signaling pathways. Its dysregulation is implicated in numerous diseases, making it a key area of research. Understanding the molecular mechanisms and identifying the genes involved can lead to new therapeutic strategies. EDITGENE provides essential tools to study this process through CRISPR-based models and screening services.
References
- 1. Brito Querido J et al.. 2024. The molecular basis of translation initiation and its regulation in eukaryotes.. Nat Rev Mol Cell Biol 25(3):168-186 PMID: 38052923
- 2. Fels JM et al.. 2026. Giant DNA viruses encode a hallmark translation initiation complex of eukaryotic life.. Cell 189(5):1423-1433.e16 PMID: 41709453
- 4. Brito Querido J et al.. 2024. The structure of a human translation initiation complex reveals two independent roles for the helicase eIF4A.. Nat Struct Mol Biol 31(3):455-464 PMID: 38287194
- 5. Thoreen CC et al.. 2012. A unifying model for mTORC1-mediated regulation of mRNA translation.. Nature 485(7396):109-13 PMID: 22552098
- 7. Ingolia NT et al.. 2011. Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes.. Cell 147(4):789-802 PMID: 22056041
